Pehub.com -- Light Sciences Oncology Inc., a Snoqualmie, Wash.-based developer of light-activated treatments for solid tumors, has raised $35 million in debt and option financing, according to a regulatory filing. VentureWire refers to the round as “bridge financing” as it considers a second stab at the IPO market. LSO had filed for an IPO in early 2006, but pulled it in 2008 citing ”unfavorable market conditions.”
